Cite

HARVARD Citation

    Woodfield, S. et al. (2016). Binimetinib inhibits MEK and is effective against neuroblastoma tumor cells with low NF1 expression. BMC cancer. 16 (1), pp. 1-10. [Online]. 
  
Back to record